Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HL-Extract is a specialized German company focused on the development, production, and distribution of standardized plant extracts for the pharmaceutical, nutraceutical, and cosmetic sectors. The company provides a diverse portfolio of botanical ingredients, ensuring high quality through rigorous extraction processes and analytical testing. In 2021, HL-Extract was acquired by Indena S.p.A., a global leader in the identification and production of plant-derived active principles. This acquisition integrated HL-Extract's expertise in the German market and its specialized product range into Indena's extensive global operations. The company is recognized for its ability to provide customized solutions and high-purity natural substances for health-related applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HL Extract.